MDxHealth shares rise on better-than-expected Q2 sales, FY26 guidance
MDxHealth shares trade higher after the company reported better-than-expected Q2 sales results and affirmed its FY26 sales guidance above estimates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.